Reports of Patent, Design, and Trade Mark Cases, Issues 13-25Published at the Patent Office Sales Branch, 2007 - Industrial property |
From inside the book
Results 1-3 of 56
Page 760
... important part in determining the rate of reaction and , indeed , whether substitution will take place at all . As I have mentioned , it had been recognised for many years that the hydroxyl group of ordinary alcohols is not a leaving ...
... important part in determining the rate of reaction and , indeed , whether substitution will take place at all . As I have mentioned , it had been recognised for many years that the hydroxyl group of ordinary alcohols is not a leaving ...
Page 791
... important to keep in mind that sales of escitalopram have been achieved in the face of the generic citalopram . Doing the best I can , I conclude that advertising has undoubtedly been important but the spend cannot be said to be out of ...
... important to keep in mind that sales of escitalopram have been achieved in the face of the generic citalopram . Doing the best I can , I conclude that advertising has undoubtedly been important but the spend cannot be said to be out of ...
Page 826
... important to them — although I suspect that could be said almost universally in relation to parties to any patent dispute . I can see that the case is particularly important to Luxim since it has spent a number of years developing the ...
... important to them — although I suspect that could be said almost universally in relation to parties to any patent dispute . I can see that the case is particularly important to Luxim since it has spent a number of years developing the ...
Contents
EDITORS INTRODUCTION | v |
CASES REPORTED IN NUMERICAL ORDER | xiv |
CASES NOTED IN JUDGMENTS AND DECISIONS REPORTED | xxiv |
Copyright | |
1 other sections not shown
Other editions - View all
Common terms and phrases
added subject matter agreement Akzo Nobel Angiotech Pharmaceuticals Inc Appeal to Court application for revocation Appointed Person BACTIGUARD chiral citalopram claimants co-proprietor's application common general knowledge comparative advertising Comptroller consent Court of Appeal decision declarations of invalidity DESIGN AND TRADE divisional applications Dr Pinkava duties earlier mark earlier trade mark enantiomers European patents evidence grounds for refusal Halliburton Energy Services hearing officer Intellectual Property Office inventive step issue jurisdiction L'Oréal licence LIFFE likelihood of confusion Lundbeck Malynicz non-use opposition parallel trading particulars of infringement patentable subject matter Patents Act 1977 Patents Court perfumes pharmaceutical Playtech prior art racemate referred registered proprietor registered trade mark registrar relation relative grounds relevant REPORTS OF PATENT restenosis skilled person smell-alike specification stent Sweet & Maxwell taxol tibolone TRADE MARK 2007 Trade Mark Application trade marks declarations United Kingdom validating amendments VITALITE Vitasoy